Nyxoah SA (NYXH)
Nyxoah Market Cap: 299.16M for May 16, 2024
Market Cap Chart
Historical Market Cap Data
Date | Value |
---|---|
May 16, 2024 | 299.16M |
May 15, 2024 | 294.57M |
May 14, 2024 | 274.78M |
May 13, 2024 | 253.84M |
May 10, 2024 | 236.06M |
May 09, 2024 | 244.38M |
May 08, 2024 | 266.46M |
May 07, 2024 | 259.00M |
May 06, 2024 | 259.00M |
May 03, 2024 | 279.94M |
May 02, 2024 | 284.82M |
May 01, 2024 | 271.91M |
April 30, 2024 | 296.72M |
April 29, 2024 | 317.52M |
April 26, 2024 | 304.61M |
April 25, 2024 | 323.83M |
April 24, 2024 | 304.47M |
April 23, 2024 | 300.59M |
April 22, 2024 | 304.04M |
April 19, 2024 | 308.34M |
April 18, 2024 | 298.30M |
April 17, 2024 | 273.92M |
April 16, 2024 | 266.75M |
April 15, 2024 | 255.28M |
April 12, 2024 | 258.43M |
Date | Value |
---|---|
April 11, 2024 | 278.79M |
April 10, 2024 | 311.21M |
April 09, 2024 | 315.51M |
April 08, 2024 | 324.69M |
April 05, 2024 | 344.48M |
April 04, 2024 | 350.50M |
April 03, 2024 | 358.82M |
April 02, 2024 | 332.72M |
April 01, 2024 | 351.65M |
March 28, 2024 | 386.93M |
March 27, 2024 | 380.33M |
March 26, 2024 | 383.49M |
March 25, 2024 | 388.94M |
March 22, 2024 | 422.21M |
March 21, 2024 | 427.08M |
March 20, 2024 | 398.69M |
March 19, 2024 | 479.86M |
March 18, 2024 | 559.31M |
March 15, 2024 | 474.55M |
March 14, 2024 | 475.41M |
March 13, 2024 | 491.19M |
March 12, 2024 | 501.80M |
March 11, 2024 | 487.46M |
March 08, 2024 | 459.36M |
March 07, 2024 | 426.67M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
Galapagos NV | 1.947B |
UCB SA | 24.99B |
Mithra Pharmaceuticals SA | 451.63M |
Celyad Oncology SA | 8.355M |
MDxHealth SA | 78.04M |
Market Cap Related Metrics
PS Ratio | 60.88 |
PEG Ratio | -0.1874 |
Price to Book Value | 2.713 |
Price | 10.43 |
Earnings Yield | -16.38% |
PEGY Ratio | -0.1874 |